159 related articles for article (PubMed ID: 31075357)
1. Primary aromatic amines and cancer: Novel mechanistic insights using 4-aminobiphenyl as a model carcinogen.
Wang S; Hanna D; Sugamori KS; Grant DM
Pharmacol Ther; 2019 Aug; 200():179-189. PubMed ID: 31075357
[TBL] [Abstract][Full Text] [Related]
2. Bioactivation of the tobacco carcinogens 4-aminobiphenyl (4-ABP) and 2-amino-9H-pyrido[2,3-b]indole (AαC) in human bladder RT4 cells.
Bellamri M; Yao L; Bonala R; Johnson F; Von Weymarn LB; Turesky RJ
Arch Toxicol; 2019 Jul; 93(7):1893-1902. PubMed ID: 31203411
[TBL] [Abstract][Full Text] [Related]
3. Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice.
Yoon JI; Kim SI; Tommasi S; Besaratinia A
Cancer Prev Res (Phila); 2012 Feb; 5(2):299-308. PubMed ID: 22086680
[TBL] [Abstract][Full Text] [Related]
4. Identification of cancer chemopreventive isothiocyanates as direct inhibitors of the arylamine N-acetyltransferase-dependent acetylation and bioactivation of aromatic amine carcinogens.
Duval R; Xu X; Bui LC; Mathieu C; Petit E; Cariou K; Dodd RH; Dupret JM; Rodrigues-Lima F
Oncotarget; 2016 Feb; 7(8):8688-99. PubMed ID: 26840026
[TBL] [Abstract][Full Text] [Related]
5. The role of DNA damage in chemical carcinogenesis of aromatic amines.
Neumann HG
J Cancer Res Clin Oncol; 1986; 112(2):100-6. PubMed ID: 3533949
[TBL] [Abstract][Full Text] [Related]
6. Assessment of exposure and susceptibility to aromatic amine carcinogens.
Kadlubar FF; Talaska G; Lang NP; Benson RW; Roberts DW
IARC Sci Publ; 1988; (89):166-74. PubMed ID: 3198199
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology.
Tannenbaum SR
Princess Takamatsu Symp; 1990; 21():351-60. PubMed ID: 2134688
[TBL] [Abstract][Full Text] [Related]
8. Formation and persistence of arylamine DNA adducts in vivo.
Beland FA; Kadlubar FF
Environ Health Perspect; 1985 Oct; 62():19-30. PubMed ID: 4085422
[TBL] [Abstract][Full Text] [Related]
9. Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice.
Sugamori KS; Brenneman D; Sanchez O; Doll MA; Hein DW; Pierce WM; Grant DM
Cancer Lett; 2012 May; 318(2):206-13. PubMed ID: 22193722
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
11. Identification of new DNA adducts in human bladder epithelia exposed to the proximate metabolite of 4-aminobiphenyl using 32P-postlabeling method.
Swaminathan S; Hatcher JF
Chem Biol Interact; 2002 Feb; 139(2):199-213. PubMed ID: 11823007
[TBL] [Abstract][Full Text] [Related]
12. Aromatic amine DNA adduct formation in chronically-exposed mice: considerations for human comparison.
Poirier MC; Beland FA
Mutat Res; 1997 May; 376(1-2):177-84. PubMed ID: 9202754
[TBL] [Abstract][Full Text] [Related]
13. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
15. Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2'-dimethyl-4-aminobiphenyl.
Jiang W; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1999 May; 156(3):187-94. PubMed ID: 10222311
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.
Turesky RJ; Le Marchand L
Chem Res Toxicol; 2011 Aug; 24(8):1169-214. PubMed ID: 21688801
[TBL] [Abstract][Full Text] [Related]
17. Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions.
Besaratinia A; Tommasi S
FASEB J; 2013 Jun; 27(6):2090-100. PubMed ID: 23449930
[TBL] [Abstract][Full Text] [Related]
18. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents.
Poirier MC; Beland FA
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):161-5. PubMed ID: 7889840
[TBL] [Abstract][Full Text] [Related]
19. Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines.
Gorlewska-Roberts KM; Teitel CH; Lay JO; Roberts DW; Kadlubar FF
Chem Res Toxicol; 2004 Dec; 17(12):1659-66. PubMed ID: 15606142
[TBL] [Abstract][Full Text] [Related]
20. DNA adducts in target and nontarget tissues of 3,2'-dimethyl-4-aminobiphenyl in rats.
Shirai T; Tada M; Kojima M; Hasegawa R; Masui T; Ito N
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):167-72. PubMed ID: 7889841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
